Clinical Trial Update: Lurasidone Effects on Tissue Glutamate in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial updates on lurasidone effects on tissue glutamate in schizophrenia and schizoaffective disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2021-03-01